Marco Monti

Marco Monti serves as Associate Professor at Sapienza University of Rome's Department of Maternal and Child Health and Urological Sciences, where he teaches Obstetrics (Corso di Laurea Ostetricia) with specific focus on childbirth assistance. His clinical expertise spans gynecological oncology, minimally invasive surgery, and reproductive medicine, supported by extensive publications in high-impact journals.

His primary research interests include:

• Gynecological cancer management (particularly ovarian and cervical malignancies)
• Fertility-sparing treatments for early-stage endometrial/cervical cancers
• Innovative endometrial preparation techniques for hysteroscopic procedures
• Non-invasive therapies for genitourinary syndrome of menopause
• Obstetric complications in high-risk pregnancies

Analysis of his 2022-2025 publications reveals three dominant trends: (1) Optimization of rapid-start hormonal protocols for outpatient hysteroscopy, (2) Advancement of PARP inhibitor therapies in ovarian cancer, and (3) Expansion into public health domains including pandemic risk assessment and disaster response. His work consistently bridges clinical practice with translational research through multicenter trials.

Dr. Monti leads two major research initiatives:

• Conservative treatment of early-stage endometrial cancer - Investigating fertility preservation and obstetric outcomes
• Conservative treatment of early-stage cervical cancer - Evaluating pregnancy outcomes after conservative management

His research receives institutional support through Sapienza University frameworks, with recent projects examining minimally invasive surgical approaches and menopausal symptom management using CO2 laser therapy.